Influence of concomitant drug use on the reporting odds ratio of hypertension and proteinuria due to the use of sunitinib or sorafenib analyzed by the FAERS database.

○Kanta Higuchi

Presentation information

Poster Presentation

(E) Pharmaceutical Health Care and Sciences

[27PO1-pm2] Clinical pharmacy services at hospital (inpatient and outpatient counselling)/Community pharmacy, home medical care, and community health care-2/Appropriate use of medicines (drug-drug interactions)-1/Pharmacotherapies (Basics)-2/(Cancer)-2/Drug information-2/Development of novel medicines and formulations/Formulation testing-2

Sun. Mar 27, 2022 3:20 PM - 5:00 PM [Room PO1] Event Hall (Bldg. 1: 1F)

3:20 PM - 5:00 PM

[27PO1-pm2-53S] Influence of concomitant drug use on the reporting odds ratio of hypertension and proteinuria due to the use of sunitinib or sorafenib analyzed by the FAERS database.

○Kanta Higuchi¹, Kyosuke Hayamizu¹, Toshihiko Hirano¹, Kenji Onda¹ (1. Dept of Clinical Pharmacology, Tokyo University of Pharmacy and Life Sciences)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[27PO1-pm2-53S] Influence of concomitant drug use on the reporting odds ratio of hypertension and proteinuria due to the use of sunitinib or sorafenib analyzed by the FAERS database.

Password